Your session is about to expire
← Back to Search
Behavioral Intervention
C-SCAT for Young Adult Cancer Management
N/A
Recruiting
Led By Suzanne Ameringer, PhD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks following timepoint 1 (timepoint 2)
Awards & highlights
Study Summary
This trial explores how a computer tool can help people better manage their symptoms and gain confidence in doing so.
Who is the study for?
This trial is for English-speaking adolescents and young adults who have been diagnosed with cancer within the last 3 months, have undergone at least one treatment cycle, and will undergo at least three more. They should be experiencing at least one symptom from their condition or treatment but must not have cognitive or physical issues that would prevent them from participating in the study.Check my eligibility
What is being tested?
The study is testing a Computerized Symptom Capture Tool (C-SCAT) against usual care to see if it improves how confident patients feel about managing their symptoms and whether it changes how they actually manage those symptoms.See study design
What are the potential side effects?
Since this trial involves a computerized tool rather than medication, traditional side effects are not expected. However, there may be indirect effects on stress or anxiety levels due to increased engagement with symptom tracking.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 weeks following timepoint 1 (timepoint 2)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks following timepoint 1 (timepoint 2)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Effects of the C-SCAT versus usual care on the of self-efficacy for symptom management at follow up (Time 2) by comparing the scores from the Patient-Reported Outcomes Measurement Information System®; PROMIS® Scale.
Effects of the C-SCAT versus usual care on the of self-efficacy for symptom management immediately post intervention (Time 1) by comparing the scores from the Patient-Reported Outcomes Measurement Information System®; PROMIS® Scale.
Effects of the C-SCAT versus usual care on the of symptom self-management behaviors at follow up (Time 2) by comparing the scores from the Symptom Self-management Behaviors Tool (SSMBT).
+1 moreSecondary outcome measures
Effects of the C-SCAT versus usual care on (satisfaction with social function) post intervention (Time 2) by comparing the PROMIS SF v2.0 Satisfaction with Social Roles and Activities.
Effects of the C-SCAT versus usual care on (social function) at baseline, by comparing the PROMIS SF v2.0 Ability to Participate in Social Roles and Activities scores.
Effects of the C-SCAT versus usual care on (social function) immediately post intervention (Time 1) by comparing the PROMIS SF v2.0 Ability to Participate in Social Roles and Activities scores.
+7 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Computerized Symptom Assessment Tool C-SCATExperimental Treatment1 Intervention
Participants will be asked to complete the C-SCAT at three of their clinic visits for cancer treatment in addition to usual care for assessing symptoms. This intervention period will last up to about 12 weeks, depending on cancer treatment schedule (for example, every 2, 3 or 4 weeks).
Group II: Usual Care Control GroupActive Control1 Intervention
Participants will follow usual care for cancer symptoms for up to 12 weeks, depending on how cancer treatment schedule (for example, every 2, 3 or 4 weeks).
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,672 Previous Clinical Trials
40,926,315 Total Patients Enrolled
Virginia Commonwealth UniversityLead Sponsor
699 Previous Clinical Trials
22,884,919 Total Patients Enrolled
Suzanne Ameringer, PhDPrincipal InvestigatorVirginia Commonwealth University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am able to complete study tasks and understand instructions.I experience symptoms due to my cancer or its treatment.I started cancer treatment within 3 months of my diagnosis and have completed at least 1 cycle.I am currently on cancer treatment and will have at least three more cycles.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Computerized Symptom Assessment Tool C-SCAT
- Group 2: Usual Care Control Group
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Could I potentially qualify for the current experiment?
"This medical trial is enrolling 126 participants who are displaying symptoms and between the ages of 15 - 29."
Answered by AI
Are there still positions available in this investigation?
"Contrary to what is listed on clinicaltrials.gov, this study has ceased recruitment efforts and does not currently look for participants; the trial had its initial post date of August 1st 2023 and was last updated July 14th 2023. Despite this fact, there are still 587 other trials actively seeking patients at present."
Answered by AI
Does this research offer an opportunity for septuagenarians to participate?
"To be accepted into this trial, applicants must fall between the ages of 15 and 29. There are 90 trials available for minors while 506 spots remain open to those over 65 years old."
Answered by AI
What aims is this experiment endeavoring to accomplish?
"The primary outcome of this trial, evaluated within a two-week period following intervention (Timepoint 1), will be to measure the impact of C-SCAT compared to standard care on self-efficacy for symptom management at follow up (Time 2). This is achieved by comparing the scores from PROMIS® Scale. Secondary outcomes include evaluating how C-SCAT versus usual care affects symptoms severity immediately post intervention (Time 1 & Time 2) via MSAS and also symptom distress at baseline using MSAS."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger